MDMA approved to treat post-traumatic stress in active-duty US soldiers

Hope that sessions of MDMA-assisted therapy could help soldiers fight longer by helping them process trauma A new doctrine could soon take hold in part of the US war on drugs: psychedelic drugs for active-duty soldiers suffering from PTSD. In two studies funded by the Department of Defense (DoD), 186 service personnel with PTSD will likely next year undergo multiple sessions of MDMA-assisted therapy. Continue reading...

Mattha Busby · Thu, Apr 30, 2026, 8:00 AM
US news | The Guardian

MDMA approved to treat post-traumatic stress in active-duty US soldiers

Hope that sessions of MDMA-assisted therapy could help soldiers fight longer by helping them process trauma

A new doctrine could soon take hold in part of the US war on drugs: psychedelic drugs for active-duty soldiers suffering from PTSD.

In two studies funded by the Department of Defense (DoD), 186 service personnel with PTSD will likely next year undergo multiple sessions of MDMA-assisted therapy.

This page shows an excerpt; reporting belongs to the original publisher. Some images or embeds may be omitted compared with the live article.